Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study. by Ahmed M Musa, Brima Younis, Ahmed Fadlalla, Catherine Royce, Manica Balasegaram, Monique Wasunna, Asrat Hailu, Tansy Edwards, Raymond Omollo, Mahmoud Mudawi, Gilbert Kokwaro, Ahmed El-Hassan, Eltahir Khalil

Connect to this object online.

A clinical algorithm for triaging patients with significant lymphadenopathy in primary health care settings in Sudan by Eltahir A.G. Khalil, Imad A. El Hag, Kamal E. Elsiddig, Mohamed E.M.O. Elsafi, Mona E.E. Elfaki, Ahmed M. Musa, Brima Y. Musa, Ahmed M. Elhassan

Connect to this object online.

Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model. by Luka Verrest, Séverine Monnerat, Ahmed M Musa, Jane Mbui, Eltahir A G Khalil, Joseph Olobo, Monique Wasunna, Wan-Yu Chu, Alwin D R Huitema, Henk D F H Schallig, Fabiana Alves, Thomas P C Dorlo

Connect to this object online.

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. by Eltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, Raymond Omollo, Ahmed M Musa, Workagegnehu Hailu, Abuzaid A Abuzaid, Thomas P C Dorlo, Zewdu Hurissa, Sisay Yifru, William Haleke, Peter G Smith, Sally Ellis, Manica Balasegaram, Ahmed M EL-Hassan, Gerard J Schoone, Monique Wasunna, Robert Kimutai, Tansy Edwards, Asrat Hailu

Connect to this object online.